Samples consisting of three sets of tumor/normal pairs for CNV analysis, four cell lines with ALK, RET, ROS1, and NTRK1 translocations, and the Horizon FFPE Quantitative Multiplex reference standard were tested for proof of principle to determine if multiple types of mutations could be detecting using this NGS assay design.